ACER - Acer Therapeutics - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

51.39M

Cash

1.553M

Avg Qtr Burn

-7.977M

Short % of Float

2.69%

Insider Ownership

13.78%

Institutional Own.

29.91%

Qtr Updated

06/30/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
OLPRUVA™ (ACER-001) Details Urea cycle disorder	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
EDSIVO™ (celiprolol) Details Genetic disorder	Phase 3 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ACER-801 (osanetant) Details Menopause, Hot flashes	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.